Ulrika Lorentzon Fagerberg

About me
Publications
CV
Public outreach and news

About me

Senior consultant and Clinical researcher, PhD in Pediatric Gastroenterology,
Hepatology and Nutrition. Working place: Dept of Pediatrics/Centre of
Clinical Research, Västmanland Hospital, Västerås, Entrance 29, SE-72189
Västerås, Sweden, telephone +4621173000.

Research

Clinical research in gastrointestinal inflammation with focus on Inflammatory
Bowel Disease (IBD).

Articles

Article: ALLERGY. 2021;76(7):2115-2122

Clinical presentation and management of food protein-induced enterocolitis syndrome in 113 Swedish children

Ullberg J; Fech-Bormann M; Fagerberg UL
Article: ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 2021;53(4):471-483

Drug survival of anti-TNF agents compared with vedolizumab as a second-line biological treatment in inflammatory bowel disease: results from nationwide Swedish registers

Rundquist S; Sachs MC; Eriksson C; Olen O; Montgomery S; Halfvarson J
Article: JMIR RESEARCH PROTOCOLS. 2020;9(12):e19748

An Intervention With Dance and Yoga for Girls With Functional Abdominal Pain Disorders (Just in TIME): Protocol for a Randomized Controlled Trial

Philipson A; Sarnblad S; Ekstav L; Eriksson M; Fagerberg UL; Moller M; Morelius E; Duberg A
Article: JOURNAL OF CROHNS & COLITIS. 2020;15(2):jjaa161-194

The Medical Management of Paediatric Crohn's Disease: an ECCO-ESPGHAN Guideline Update

van Rheenen PF; Aloi M; Assa A; Bronsky J; Escher JC; Fagerberg UL; Gasparetto M; Gerasimidis K; Griffiths A; Henderson P; Koletzko S; Kolho K-L; Levine A; van Limbergen J; de Carpi FJM; Navas-Lopez VM; Oliva S; de Ridder L; Russell RK; Shouval D; Spinelli A; Turner D; Wilson D; Wine E; Ruemmele FM
Article: ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 2020;52(4):655-668

Healthcare use, work loss and total costs in incident and prevalent Crohn's disease and ulcerative colitis: results from a nationwide study in Sweden

Khalili H; Everhov AH; Halfvarson J; Ludvigsson JF; Askling J; Myrelid P; Soderling J; Olen O; Neovius M
Article: SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY. 2020;55(4):430-435

The use of ICD codes to identify IBD subtypes and phenotypes of the Montreal classification in the Swedish National Patient Register

Shrestha S; Olen O; Eriksson C; Everhov AH; Myrelid P; Visuri I; Ludvigsson JF; Schoultz I; Montgomery S; Sachs MC; Halfvarson J; Olsson M; Hjortswang H; Bengtsson J; Strid H; Andersson M; Jaghult S; Eberhardson M; Nordenvall C; Bjork J; Fagerberg UL; Rejler M; Grip O; Karling P; Block M; Angenete E; Hellstrom PM; Gustaysson A
Article: ACTA PAEDIATRICA. 2019;108(6):1140-1143

Questionnaire showed that Swedish paediatric clinics complied well with the revised European guidelines for diagnosing coeliac disease

Myleus A; Stenhammar L; Hogberg L; Browaldh L; Daniels I-M; Fagerberg UL; Gudjonsdottir AH; Malmquist M; Sandstrom O; Ivarsson A
Article: NUTRIENTS. 2019;11(2):E414-414

Exclusive Enteral Nutrition: Clinical Effects and Changes in Mucosal Cytokine Profile in Pediatric New Inflammatory Bowel Disease

Rolandsdotter H; Jonsson-Videsater K; Fagerberg UL; Finkel Y; Eberhardson M
Article: ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 2018;48(5):523-537

Malignancy and mortality in paediatric-onset inflammatory bowel disease: a 3-year prospective, multinational study from the paediatric IBD Porto group of ESPGHAN

Joosse ME; Aardoom MA; Kemos P; Turner D; Wilson DC; Koletzko S; Martin-de-Carpi J; Fagerberg UL; Spray C; Tzivinikos C; Sladek M; Shaoul R; Roma-Giannikou E; Bronsky J; Serban DE; Ruemmele FM; Garnier-Lengline H; Veres G; Hojsak I; Kolho KL; Davies IH; Aloi M; Lionetti P; Hussey S; Veereman G; Braegger CP; Trindade E; Wewer AV; Hauer AC; de Vries ACH; Boneh RS; Shabat CS; Levine A; de Ridder L
Article: JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION. 2018;66(4):e103-e107

Mucosal Cytokine Profiles After Induction Therapy With Granulocyte/Monocyte Apheresis in New-onset Inflammatory Colitis

Rolandsdotter H; Jonsson-Videsater K; Fagerberg UL; Eberhardson M; Finkel Y
Article: JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION. 2018;66(1):84-89

Granulocyte and Monocyte Apheresis for Induction of Remission in Children With New-Onset Inflammatory Bowel Colitis

Rolandsdotter H; Eberhardson M; Fagerberg UL; Finkel Y
Article: JAMA PEDIATRICS. 2017;171(10):984-991

Use of Laboratory Markers in Addition to Symptoms for Diagnosis of Inflammatory Bowel Disease in Children A Meta-analysis of Individual Patient Data

Holtman GA; Lisman-van Leeuwen Y; Day AS; Fagerberg UL; Henderson P; Leach ST; Perminow G; Mack D; van Rheenen PF; de Vijver EV; Wilson DC; Reitsma JB; Berger MY
Article: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2017;18(3):E575-575

Serum-Infliximab Trough Levels in 45 Children with Inflammatory Bowel Disease on Maintenance Treatment

Rolandsdotter H; Marits P; Sundin U; Wikstrom A-C; Fagerberg UL; Finkel Y; Eberhardson M
Article: ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 2017;45(4):519-532

Long-term outcome of infliximab treatment in chronic active ulcerative colitis: a Swedish multicentre study of 250 patients

Angelison L; Almer S; Eriksson A; Karling P; Fagerberg U; Halfvarson J; Thorn M; Bjork J; Hindorf U; Lofberg R; Bajor A; Hjortswang H; Hammarlund P; Grip O; Torp J; Marsal J; Hertervig E
Article: JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION. 2015;60(3):339-346

Faecal Calprotectin in Suspected Paediatric Inflammatory Bowel Disease

Degraeuwe PLJ; Beld MPA; Ashorn M; Canani RB; Day AS; Diamanti A; Fagerberg UL; Henderson P; Kolho K-L; Van de Vijver E; van Rheenen PF; Wilson DC; Kessels AGH
Article: JOURNAL OF CROHNS & COLITIS. 2014;8(10):1179-1207

Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn's disease

Ruemmele FM; Veres G; Kolho KL; Griffiths A; Levine A; Escher JC; Dias JA; Barabino A; Braegger CP; Bronsky J; Buderus S; Martin-de-Carpi J; De Ridder L; Fagerberg UL; Hugot JP; Kierkus J; Kolacek S; Koletzkou S; Lionetti P; Miele E; Navas Lopez VM; Paerregaard A; Russell RK; Serban DE; Shaoul R; Van Rheenen P; Veereman G; Weiss B; Wilson D; Dignass A; Eliakim A; Winter H; Turner D
Article: SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY. 2014;49(8):950-957

Pediatric Crohn's disease from onset to adulthood: granulomas are associated with an early need for immunomodulation

Idestrom M; Rubio CA; Onelov E; Henter J-I; Fagerberg UL; Finkel Y
Article: INFLAMMATORY BOWEL DISEASES. 2014;20(2):291-300

Malignancy and Mortality in Pediatric Patients with Inflammatory Bowel Disease: A Multinational Study from the Porto Pediatric IBD Group

de Ridder L; Turner D; Wilson DC; Koletzko S; Martin-de-Carpi J; Fagerberg UL; Spray C; Sladek M; Shaoul R; Roma-Giannikou E; Bronsky J; Serban DE; Cucchiara S; Veres G; Ruemmele FM; Hojsak I; Kolho KL; Davies IH; Aloi M; Lionetti P; Veereman-Wauters G; Braegger CP; Trindade E; Wewer AV; Hauer A; Levine A
Article: JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION. 2012;55(3):340-361

Management of Pediatric Ulcerative Colitis: Joint ECCO and ESPGHAN Evidence-based Consensus Guidelines

Turner D; Levine A; Escher JC; Griffiths AM; Russell RK; Dignass A; Dias JA; Bronsky J; Braegger CP; Cucchiara S; de Ridder L; Fagerberg UL; Hussey S; Hugot J-P; Kolacek S; Kolho KL; Lionetti P; Pcerregaard A; Potapov A; Rintala R; Serban DE; Staiano A; Sweeny B; Veerman G; Veres G; Wilson DC; Ruemmele FM
Article: INFLAMMATORY BOWEL DISEASES. 2012;18(3):520-528

Manifestations of small bowel disease in pediatric Crohn's disease on magnetic resonance enterography

Torkzad MR; Ullberg U; Nystrom N; Blomqvist L; Hellstrom P; Fagerberg UL
Article: EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY. 2009;21(10):1168-1176

Infliximab in clinical routine: experience with Crohn's disease and biomarkers of inflammation over 5 years

Lonnkvist MH; Befrits R; Lundberg JO; Lundahl J; Fagerberg UL; Hjortswang H; van Hage M; Hellstrom PM
Article: JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION. 2007;45(4):414-420

Fecal calprotectin:: A quantitative marker of colonic inflammation in children with inflammatory bowel disease

Fagerberg UL; Loof L; Lindholm J; Hansson L-O; Finkel Y
Article: ACTA PAEDIATRICA. 2007;96(7):1076-1079

No evidence for a clear link between active intestinal inflammation and autism based on analyses of faecal calprotectin and rectal nitric oxide

Fernell E; Fagerberg UL; Hellstrom PM
Article: ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 2006;24(2):331-342

Adverse events leading to modification of therapy in a large cohort of patients with inflammatory bowel disease

Hindorf U; Lindqvist M; Hildebrand H; Fagerberg U; Almer S
Article: JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION. 2005;40(4):450-455

Colorectal inflammation is well predicted by fecal calprotectin in children with gastrointestinal symptoms

Fagerberg UL; Lööf L; Myrdal U; Hansson LO; Finkel Y
Article: JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION. 2003;37(4):468-472

Fecal calprotectin levels in healthy children studied with an improved assay

Fagerberg UL; Lööf L; Merzoug RD; Hansson LO; Finkel Y
Show more

All other publications

Review: SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY. 2019;54(9):1089-1101

Swedish Inflammatory Bowel Disease Register (SWIBREG) - a nationwide quality register

Ludvigsson JF; Andersson M; Bengtsson J; Eberhardson M; Fagerberg UL; Grip O; Halfvarson J; Hjortswang H; Jaghult S; Karling P; Nordenvall C; Olen O; Olsson M; Rejler M; Strid H; Myrelid P
Thesis / dissertation: 2007

Fecal calprotectin in children with special reference to inflammatory bowel disease

Fagerberg, Ulrika Lorentzon

Employments

Affiliated to Research, Department of Women's and Children's Health, Karolinska Institutet, 2024-2027

Degrees and Education

Doctor Of Philosophy, Department of Women's and Children's Health, Karolinska Institutet, 2007

About me

Research

Articles

All other publications

Employments

Degrees and Education

News from KI

Events from KI